- Report
- October 2024
- 181 Pages
Global
From €3402EUR$3,545USD£2,835GBP
€3780EUR$3,939USD£3,150GBP
- Report
- February 2025
- 100 Pages
Global
From €5709EUR$5,950USD£4,758GBP
- Report
- March 2025
- 92 Pages
Global
From €5373EUR$5,600USD£4,478GBP
- Report
- March 2025
- 92 Pages
Global
From €3500EUR$3,907USD£3,019GBP
- Report
- October 2023
- 146 Pages
Global
From €3385EUR$3,528USD£2,821GBP
€3982EUR$4,150USD£3,318GBP
The bioprosthetic market within the context of orthopedic devices is a rapidly growing sector of the medical device industry. Bioprosthetics are artificial implants made from biological materials, such as collagen, that are designed to replace or repair damaged or diseased tissue. These implants are used in a variety of orthopedic procedures, including joint replacement, spinal fusion, and fracture repair. Bioprosthetics offer a number of advantages over traditional implants, including improved durability, flexibility, and biocompatibility.
Bioprosthetics are becoming increasingly popular in the orthopedic device market due to their ability to provide a more natural feel and improved patient outcomes. As a result, many companies are investing in the development of new bioprosthetic products and technologies. Some of the leading companies in the bioprosthetic market include Zimmer Biomet, Stryker, Smith & Nephew, and Medtronic. Show Less Read more